Bull case
The bull case prices SOLS at 30x on FY1 earnings, assuming continued execution and no meaningful deceleration in the core business.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where SOLS stock could go
The bull case prices SOLS at 30x on FY1 earnings, assuming continued execution and no meaningful deceleration in the core business.
At 22x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
If investor confidence fades or macro conditions deteriorate, a 18x multiple contraction could push SOLS down roughly 56% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Solstice Advanced Materials is a specialty chemicals company that develops and manufactures high-performance materials for critical industrial applications. It generates revenue primarily through sales of specialty refrigerants (~40%), semiconductor manufacturing materials (~30%), and advanced cooling solutions for data centers (~20%). The company's moat lies in its proprietary chemical formulations and deep technical expertise in materials science for demanding applications where performance and reliability are paramount.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q4 2025 | $-0.22/$0.36 | -161.5% | $969M/$924M | +4.8% |
| Q1 2026 | $0.26/$0.40 | -35.0% | $987M/$922M | +7.1% |
| Q2 2026 | $0.63/$0.61 | +2.6% | $991M/$974M | +1.8% |
SOLS beat EPS estimates in 1 of 3 tracked quarters. Mixed delivery makes the upcoming report a key data point for re-rating.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $59 — implies -31.5% from today's price.
| Metric | SOLS | S&P 500 | Financial Services | 5Y Avg SOLS |
|---|---|---|---|---|
| Forward PE | 31.9x | 18.8x+69% | 10.7x+198% | — |
| Trailing PE | 57.4x | 24.4x+135% | 13.6x+323% | 32.6x+76% |
| PEG Ratio | — | 1.66x | 0.95x | — |
| EV/EBITDA | 16.2x | 15.2x | 11.4x+43% | 10.1x+61% |
| Price/FCF | — | 20.7x | 11.1x | — |
| Price/Sales | 3.5x | 3.1x+13% | 2.3x+50% | 2.0x+76% |
| Dividend Yield | — | 1.91% | 2.63% | — |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolSOLS generates 11.5% ROE and 3.8% return on assets — the two primary signals for banking profitability. FCF-based metrics are not applicable to financial companies.
Revenue, profitability, and return on capital
ROIC, leverage, and debt serviceability
Traditional FCF and debt/FCF ratios are not meaningful for financial companies. Focus on ROE and ROA above.
How capital is returned to owners
All figures from the trailing twelve months. For financial companies, ROE and ROA are the primary health signals — FCF-based metrics are not applicable.
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated April 29, 2026
SOLS is currently trading at a Price-to-Earnings (P/E) ratio of 55.8x, significantly above the US Chemicals industry average of 28.2x and the peer average of 25.1x. This elevated valuation suggests potential overvaluation, which could lead to a price correction if market sentiment shifts.
The company's debt-to-equity ratio stands at 169.4%, indicating a high level of leverage. Although interest payments are covered by EBIT, the debt is not well-supported by operating cash flow, raising concerns about financial stability.
SOLS faces execution risks in its Refrigerants & Applied Solutions and Electronic & Specialty Materials segments, where reliance on higher multiple expectations could lead to volatility. Any failure to meet growth targets could adversely impact stock performance.
Despite revenue growth, SOLS has experienced a decline in net income year-over-year due to rising operating costs and investments in low global warming potential refrigerants. This trend could affect future profitability and investor confidence.
Projected revenue growth for SOLS is at 4.9% per annum, which lags behind the US market's forecast of 11.1%. This slower growth could hinder the company's competitive position and investor appeal.
The transition to low global warming potential refrigerants presents both opportunities and challenges for SOLS. Regulatory pressures and associated costs could impact profitability and operational efficiency.
The specialty chemicals market is highly competitive, with fluctuating pricing dynamics that could affect SOLS's margins. Increased competition may lead to pricing pressures, impacting revenue and profitability.
As a newly independent entity following its spin-off from Honeywell, SOLS is navigating a transition period that introduces uncertainties. This transition may affect operational stability and market perception.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated April 29, 2026
Solstice is experiencing robust growth in segments like nuclear energy, refrigerants, and electronic materials. The company's role in providing uranium hexafluoride (UF6) conversion services positions it to benefit from the resurgence of nuclear power and government support for domestic supply chains.
Solstice is well-positioned to capitalize on long-term trends such as sustainability transitions in cooling and building solutions, and the proliferation of artificial intelligence and advanced computing. These trends are expected to drive demand for Solstice's innovative materials and services.
Despite some profitability pressures, Solstice has reaffirmed its full-year guidance for net sales. Management expects continued revenue and EBITDA growth in 2026, supported by disciplined capital allocation and innovation.
Some analysts have a 'Buy' or 'Moderate Buy' consensus, with price targets suggesting potential upside. For instance, some analysts have set 12-month price targets averaging around $89.20, indicating a potential upside of nearly 10%.
Solstice is described as a key service provider in the nuclear energy sector, benefiting from a constrained global supply chain for critical minerals. This strategic positioning enhances its competitive advantage and growth prospects.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
SOL SOLS Solstice Advanced Materials Inc. | $13.6B | 31.9x | +3.2% | 5.3% | Buy | +6.9% |
MTR MTRN Materion Corporation | $5.7B | 42.8x | +5.9% | 4.0% | Buy | -41.5% |
KAL KALU Kaiser Aluminum Corporation | $3.0B | 17.8x | +8.2% | 4.1% | Hold | -9.5% |
HWK HWKN Hawkins, Inc. | $3.4B | 41.0x | +8.1% | 7.5% | Buy | — |
ASI ASIX AdvanSix Inc. | $535M | 13.8x | +0.9% | 0.7% | Buy | +10.8% |
EMN EMN Eastman Chemical Company | $8.3B | 11.4x | +0.1% | 4.6% | Buy | +10.2% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
SOLS does not currently return meaningful capital to shareholders.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw |
|---|---|---|
| 2026 | $0.15 | — |
Common questions answered from live analyst data and company financials.
Solstice Advanced Materials Inc. (SOLS) is rated Buy by Wall Street analysts as of 2026. Of 4 analysts covering the stock, 2 rate it Buy or Strong Buy, 2 rate it Hold, and 0 rate it Sell or Strong Sell. The consensus 12-month price target is $92, implying +6.9% from the current price of $86. The bear case scenario is $38 and the bull case is $79.
The Wall Street consensus price target for SOLS is $92 based on 4 analyst estimates. The high-end target is $101 (+18.0% from today), and the low-end target is $80 (-6.5%). The base case model target is $60.
SOLS trades at 31.9x times forward earnings. The stock trades at a notable premium to the broad market, which is typical for businesses with strong free cash flow and above-average growth expectations. Based on current multiples versus the peer group, the relative model signals expensive versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for SOLS in 2026 are: (1) Overvaluation Concerns — SOLS is currently trading at a Price-to-Earnings (P/E) ratio of 55. (2) High Debt-to-Equity Ratio — The company's debt-to-equity ratio stands at 169. (3) Execution Risk — SOLS faces execution risks in its Refrigerants & Applied Solutions and Electronic & Specialty Materials segments, where reliance on higher multiple expectations could lead to volatility. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates SOLS will report consensus revenue of $4.0B (+3.2% year-over-year) and EPS of $1.40 (+7.8% year-over-year) for the upcoming fiscal year. The following year, analysts project $4.3B in revenue.
Solstice Advanced Materials Inc. is expected to report its next earnings on approximately 2026-08-05. Consensus expects EPS of $0.77 and revenue of $1.1B. Over recent quarters, SOLS has beaten EPS estimates 33% of the time.
Solstice Advanced Materials Inc. (SOLS) generated $79M in free cash flow over the trailing twelve months — a free cash flow margin of 2.0%. SOLS returns capital to shareholders through and share repurchases ($0 TTM).